LPL Financial’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,533
Closed -$187K 4440
2021
Q3
$187K Sell
10,533
-1,400
-12% -$26.4K ﹤0.01% 4009
2021
Q2
$245K Sell
11,933
-200
-2% -$3.94K ﹤0.01% 3759
2021
Q1
$240K Buy
12,133
+878
+8% +$20.4K ﹤0.01% 3634
2020
Q4
$209K Sell
11,255
-260
-2% -$5.7K ﹤0.01% 3490
2020
Q3
$290K Buy
11,515
+1,950
+20% +$48.6K ﹤0.01% 2928
2020
Q2
$292K Buy
+9,565
New +$293K ﹤0.01% 2854

Other funds holding RCEL

LPL Financial's RCEL Position: Q4 2021 in Review

LPL Financial sold out of Avita Medical (RCEL) in Q4 2021, closing a stake of 10,533 shares — an estimated $187K sold.

LPL Financial first reported a position in RCEL in Q2 2020 and held it in 6 quarters. The position peaked at $292K in Q2 2020. 62 funds tracked by Wall St. Rank hold RCEL as of Q4 2021.

  • LPL Financial reported no remaining Avita Medical position as of Q4 2021 after selling out during the quarter.
  • LPL Financial sold 10,533 Avita Medical shares in Q4 2021, an estimated $187K.
  • LPL Financial first reported a position in Avita Medical in Q2 2020 and held it in 6 quarters.
  • LPL Financial's Avita Medical position peaked at $292K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held Avita Medical as of Q4 2021.

Based on LPL Financial's 13F filing for Q4 2021, filed 14 Feb 2022.